Cardiology
Conference Coverage
Early estrogen loss increases cardiovascular risk in women
Clinicians should especially be aware of functional hypothalamic amenorrhea as a condition that could increase women’s risk of cardiovascular...
From the Journals
Study reveals racial disparities in advanced HF therapies
White adults were twice as likely as Black adults to receive a ventricular assist device or heart transplant.
From the Journals
Four commonly abused drugs linked with atrial fibrillation
All four drugs – cocaine, methamphetamine, opioids, and cannabis – whether stimulants or depressants – cause “quite dramatic and often rapid...
From the Journals
Myocarditis after COVID vax rare and mild in teens
Myocarditis in adolescents after Pfizer mRNA vaccination is rare with a mild and benign course and a favorable long-term prognosis, new data...
From the Journals
Wake-up call on sleep and cardiovascular health
“Our study is the first to show that sleep metrics add independent predictive value for CVD events over and above the original seven...
Conference Coverage
Don’t be afraid of weight gain with hyperthyroid treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
Feature
More data suggest preexisting statin use improves COVID outcomes
The researchers saw lower mortality and clinical severity among statin users.
From the Journals
Diabetes becoming less potent risk factor for CVD events
Diabetes is no longer equal to cardiovascular disease as a risk factor for cardiovascular events, according to a population-based study in Ontario...
Feature
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
Latest News
Screening gaps miss childhood heart problems
Clinical diagnosis of homozygous familial hypercholesterolemia can be based on LDL cholesterol levels, family history, and the presence of...
From the Journals
Finerenone benefits T2D across spectrum of renal function
Finerenone treatment of people with type 2 diabetes and albuminuria improved outcomes, compared with placebo regardless of renal functional status...